Prudential Financial’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,673
| Closed | -$487K | – | 2734 |
|
|
2023
Q2 | $487K | Buy |
12,673
+440
| +4% | +$11.3K | ﹤0.01% | 2127 |
|
|
2023
Q1 | $283K | Sell |
12,233
-20
| -0.2% | -$477 | ﹤0.01% | 2287 |
|
|
2022
Q4 | $321K | Sell |
12,253
-6,580
| -35% | -$146K | ﹤0.01% | 2224 |
|
|
2022
Q3 | $370K | Buy |
18,833
+390
| +2% | +$7.82K | ﹤0.01% | 2206 |
|
|
2022
Q2 | $323K | Buy |
+18,443
| New | +$290K | ﹤0.01% | 2315 |
|
|
2020
Q4 | – | Sell |
-2,189
| Closed | -$27K | – | 2518 |
|
|
2020
Q3 | $27K | Hold |
2,189
| – | – | ﹤0.01% | 2408 |
|
|
2020
Q2 | $25K | Buy |
+2,189
| New | +$30.2K | ﹤0.01% | 2380 |
|
|
2020
Q1 | – | Sell |
-3,895
| Closed | -$23K | – | 2470 |
|
|
2019
Q4 | $23K | Buy |
3,895
+918
| +31% | +$4.99K | ﹤0.01% | 2414 |
|
|
2019
Q3 | $16K | Sell |
2,977
-4,799
| -62% | -$31.9K | ﹤0.01% | 2402 |
|
|
2019
Q2 | $60K | Buy |
7,776
+1,860
| +31% | +$28.3K | ﹤0.01% | 2415 |
|
|
2019
Q1 | $118K | Buy |
+5,916
| New | +$103K | ﹤0.01% | 2366 |
|
Prudential Financial's KDNY Position: Q3 2023 in Review
Prudential Financial sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 12,673 shares — an estimated $487K sold.
Prudential Financial first reported a position in KDNY in Q1 2019 and held it in 11 quarters. The position peaked at $487K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Prudential Financial reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Prudential Financial sold 12,673 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $487K.
- Prudential Financial first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2019 and held it in 11 quarters.
- Prudential Financial's Chinook Therapeutics, Inc. Common Stock position peaked at $487K in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Prudential Financial's 13F filing for Q3 2023, filed 13 Nov 2023.